Qvanteq

About:

Qvanteq is a medtech startup company, developing surface technology that can be applied onto any coronary stent.

Website: http://www.qvanteq.com

Top Investors: Verve Ventures, Venture Kick

Description:

Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012. Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.

Total Funding Amount:

4.01M CHF

Headquarters Location:

Zürich, Zurich, Switzerland

Founded Date:

2009-01-01

Contact Email:

info(AT)qvanteq.com

Founders:

Arik Zucker

Number of Employees:

1-10

Last Funding Date:

2013-02-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai